RUNX1 and acute myeloid leukemia: Thus, these cases fall within the provisional entity of AML with mutated RUNX1 defined by the 4th edition of the WHO Classification of Tumours of Heamatopoietic and Lymphoid Tissues [1], with concordant clinical features and an adverse risk based on European Leukemia Network stratification [73].